Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Williams

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 6, 2004
Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumoursR J Griffin, H Monzen, B W Williams, et al.
Journal of Clinical Psychopharmacology|October 22, 2015
Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety DisorderJanet B W Williams, Kenneth A Kobak, Earl Giller, et al.
Journal of the International Neuropsychological Society : JINS|April 2, 2003
Ischemic stroke and depressionDavid W Desmond, Robert H Remien, Joan T Moroney, et al.
Experimental and Clinical Psychopharmacology|July 22, 2021
SIGH, what's in a name? An examination of the factor structure and criterion validity of the (Structured Interview Guide for the) Hamilton Anxiety scale (SIGH-A) in a sample of African American adults with co-occurring trauma experience and heavy alcohol useRussell M Marks, Melanie E Bennett, Janet B W Williams, et al.
Technology in Cancer Research & Treatment|November 13, 2007
Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapyR J Griffin, B W Williams, J C Bischof, et al.
Biochimica Et Biophysica Acta|November 17, 1989
On the use of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine in the study of lipid polymorphismC D Stubbs, B W Williams, L T Boni, et al.
The American Journal of Psychiatry|June 1, 2004
Clinical utility as a criterion for revising psychiatric diagnosesMichael B First, Harold Alan Pincus, John B Levine, et al.
Journal of Affective Disorders|August 30, 2008
The PHQ-8 as a measure of current depression in the general populationKurt Kroenke, Tara W Strine, Robert L Spitzer, et al.
Journal of Clinical Psychopharmacology|January 15, 2009
Sources of unreliability in depression ratingsKenneth A Kobak, Brianne Brown, Ian Sharp, et al.
International Clinical Psychopharmacology|May 24, 2007
A novel approach to rater training and certification in multinational trialsElizabeth Jeglic, Kenneth A Kobak, Nina Engelhardt, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 6, 2004
Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumoursR J Griffin, H Monzen, B W Williams, et al.
Journal of Clinical Psychopharmacology|October 22, 2015
Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety DisorderJanet B W Williams, Kenneth A Kobak, Earl Giller, et al.
Journal of the International Neuropsychological Society : JINS|April 2, 2003
Ischemic stroke and depressionDavid W Desmond, Robert H Remien, Joan T Moroney, et al.
Experimental and Clinical Psychopharmacology|July 22, 2021
SIGH, what's in a name? An examination of the factor structure and criterion validity of the (Structured Interview Guide for the) Hamilton Anxiety scale (SIGH-A) in a sample of African American adults with co-occurring trauma experience and heavy alcohol useRussell M Marks, Melanie E Bennett, Janet B W Williams, et al.
Technology in Cancer Research & Treatment|November 13, 2007
Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapyR J Griffin, B W Williams, J C Bischof, et al.
Biochimica Et Biophysica Acta|November 17, 1989
On the use of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine in the study of lipid polymorphismC D Stubbs, B W Williams, L T Boni, et al.
The American Journal of Psychiatry|June 1, 2004
Clinical utility as a criterion for revising psychiatric diagnosesMichael B First, Harold Alan Pincus, John B Levine, et al.
Journal of Affective Disorders|August 30, 2008
The PHQ-8 as a measure of current depression in the general populationKurt Kroenke, Tara W Strine, Robert L Spitzer, et al.
Journal of Clinical Psychopharmacology|January 15, 2009
Sources of unreliability in depression ratingsKenneth A Kobak, Brianne Brown, Ian Sharp, et al.
International Clinical Psychopharmacology|May 24, 2007
A novel approach to rater training and certification in multinational trialsElizabeth Jeglic, Kenneth A Kobak, Nina Engelhardt, et al.
Pageof 7